iOnctura announces FDA clearance of IND application for roginolisib, a first-in-class allosteric modulator of PI3Kδ ...Middle East

Roginolisib is in development for solid and hematologic malignancies including uveal melanoma GENEVA and AMSTERDAM, Oct. 31, 2023 /PRNewswire/ -- iOnctura, a clinical-stage biotech developing selective cancer therapies against targets that play critical roles in multiple tumor survival...

Read More Details
Finally We wish PressBee provided you with enough information of ( iOnctura announces FDA clearance of IND application for roginolisib, a first-in-class allosteric modulator of PI3Kδ )

Also on site :

• ‘Up close and personal’ – Taylor Swift and Travis Kelce share intimate date night as onlooker gives insight into romance
• Italy holds referendum on easing citizenship rules
• Ukrainian drone attacks force Moscow airport closures